Skip to main content
. 2019 Aug 1;105(4):999–1012. doi: 10.3324/haematol.2018.207001

Figure 1.

Figure 1.

Characterization of CD99 expression in acute myeloid leukemia (AML) datasets. (A) Relative expression of CD99 in 23 AML cases compared with six healthy donors in the GSE7186 dataset. (B) Relative expression of CD99 in 542 AML cases compared with 74 healthy donors in the GSE13159 dataset. (C) Characterization of CD99 transcript expression in 246 patients with AML from the GSE106291 dataset. (D) 23 human tissue samples obtained from GSE30377 dataset were sorted into CD34+CD38, CD34+CD38+, CD34CD38-and CD34CD38+ and analyzed for CD99 expression. (E) Relative expression of CD99 in 37 patients with FLT3-ITD compared with that in 149 patients without FLT3-ITD (WT) in the TCGA dataset. N: number (**** P<0.0001; *** P<0.001; ** P<0.01; *P<0.05).